Altimmune
ALT
ALT
36 hedge funds and large institutions have $41.4M invested in Altimmune in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $52.6M → $41.4M (-$11.2M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
36
Holding in Top 10
2
Calls
$72K
Puts
$42K
Top Buyers
| 1 | +$1.5M | |
| 2 | +$473K | |
| 3 | +$81K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$79.4K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$34.4K |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$455K | |
| 3 | -$271K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$98K |
| 5 |
Goldman Sachs
New York
|
-$32K |